Protocol Overview
Dosing Protocol
Standard Recovery
250 mcg
1x daily (AM)
Subcutaneous near injury
4-6 weeks
Aggressive Healing
500 mcg
4-8 weeks
Maintenance
Every other day
Subcutaneous
2-4 weeks
250 mcg blend = 125 mcg BPC-157 + 125 mcg TB-500 (low end; BPC-157 is adequate, TB-500 is sub-therapeutic)
500 mcg blend = 250 mcg BPC-157 + 250 mcg TB-500 (standard BPC-157 dose; TB-500 still below typical 2mg target)
2 mg blend = 1 mg BPC-157 + 1 mg TB-500 (higher dose approach; recommended when TB-500 activity is the primary goal)
4 mg blend = 2 mg BPC-157 + 2 mg TB-500 (full therapeutic TB-500 dose; monitor BPC-157 at this level)
Note: If maximizing TB-500 activity (e.g., systemic anti-inflammatory, fibrosis reduction), consider dosing 2–4 mg of this blend per injection. For localized BPC-157 healing focus only, 250–500 mcg is sufficient.
Key principle: Inject as close to the injury site as possible for localized healing. For systemic recovery benefits, subcutaneous abdominal injection is appropriate.
Reconstitution Instructions
Materials Needed
BPC-157 + TB-500 blend vial (10mg + 10mg)
Bacteriostatic water (2mL)
3mL mixing syringe (18-20ga)
Insulin syringes (29-31ga) for dosing
Alcohol swabs
Reconstitution Steps
Clean vial stopper with alcohol
Draw 2mL bacteriostatic water
Inject slowly down the vial wall
Gently swirl (never shake)
Wait 5 minutes for full dissolution
Concentration: 10,000 mcg/mL
0.025 mL
2.5 units
0.05 mL
5 units
1,000 mcg
0.10 mL
10 units
2,000 mcg
0.20 mL
20 units
Administration Guide
Injection Sites
Near injury: Subcutaneous as close to injury as possible
Shoulder: Over deltoid/rotator cuff area
Knee: Medial or lateral knee
Systemic: Abdomen, 2 inches from navel
Timing & Storage
Timing: Morning on an empty stomach
Vial duration: ~80 days at 250mcg/day
Storage: Refrigerate 2-8°C, use within 30 days
Do not freeze reconstituted solution
Expected Timeline
Side Effects & Monitoring
Common Side Effects
Injection site redness or irritation (mild, transient)
Mild dizziness (uncommon)
Warmth or flushing at injection site
Mild lethargy during first few days
Both BPC-157 and TB-500 have excellent safety profiles in research literature with no significant adverse effects at standard doses.
Precautions
May theoretically promote angiogenesis in existing tumors
Avoid if active cancer or cancer history (precautionary)
Limited human clinical trial data
Not recommended during pregnancy or breastfeeding
Stacking Recommendations
Compatible Compounds
GHK-Cu: Tissue remodeling and collagen support
Ipamorelin: GH release for recovery enhancement
Glutathione: Antioxidant support during healing
Collagen peptides: Building blocks for repair
NAD+: Cellular energy for tissue regeneration
Popular Stacks
Ultimate Healing: BPC-157/TB-500 blend + GHK-Cu + Ipamorelin
Joint Recovery: BPC-157/TB-500 + Collagen + Glutathione
Athletic Recovery: BPC-157/TB-500 + CJC-1295/Ipamorelin
Blood Work Recommendations
Inflammatory
CRP, ESR, IL-6
Baseline, Week 4
Basic Panel
CBC, CMP
Liver Function
ALT, AST
Blood work is primarily to track healing-related inflammatory markers. CRP and ESR should trend downward as healing progresses.
Related Tools & Resources
Related Resources